Login / Signup

Integrated safety and efficacy analysis of dasiglucagon for treatment of severe hypoglycaemia in individuals with type 1 diabetes.

Simon R HellerTadej BattelinoTimothy S BaileyThomas R PieberUlrike HoevelmannLeona Plum-MörschelAnita E MelgaardRonnie AronsonLinda A DiMeglioThue JohansenThomas Danne
Published in: Diabetes, obesity & metabolism (2023)
NCT03378635, NCT03688711, NCT02660008, NCT03895697, NCT03216226, NCT02367053 This article is protected by copyright. All rights reserved.
Keyphrases
  • type diabetes